November 26, 2018

Five things you should know about BioBridge Global

Breaking down acronyms with the experts who work with them day in and day out
November 19, 2018

Adrienne Mendoza, Vice President of Global Quality and Compliance, helps BioBridge Global and its subsidiaries ensure cGMP (current Good Manufacturing Practices) throughout every process. She answers the basic question – “What is cGMP?” – and then adds some background in a video:

What is cGMP?

cGMP standards specify how to train personnel and qualify equipment, how to document procedures and facilities within our organization and how to carry out critical functions within every process performed at BioBridge Global. The “current” part of cGMP is an important piece because the standards and regulations around manufacturing processes are constantly changing.

GMPs specify what actions must be taken to ensure products, and their manufacturing processes, are designed and controlled to prevent sources of contamination that could lead to impure, ineffective or unsafe products.

November 12, 2018

Amid growth and the expansion of the local economy, the field of biosciences and healthcare can help San Antonio stand out, a member of the BioBridge Global board of directors told an industry meeting recently.

“When it comes to being competitive and finding the value proposition in where San Antonio differentiates itself, we have found that that’s in bioscience, and that focus is in our outbound marketing and outreach,” Jenna Saucedo-Herrera, president and CEO of the San Antonio Economic Development Foundation and BBG board member, told the Health Cell’s October luncheon.

Annual GenCure Remembrance Celebration honors families of tissue donors
November 5, 2018

The themes at the annual GenCure Remembrance Celebration were simple: Darkness and light.

Around 125 tissue donor families, staff, and community at large attended the event led by Susan Smith, Grief Support and Life Legacies Manager at GenCure.

The celebration also included a guest speaker, Darwin Huartson, community coordinator from Porter Loring Mortuaries and a longtime grief and bereavement counselor.

Early on in the event, it became clear that the group was special.

“Tonight is a celebration of our loved ones, of us here, of families,” Susan said. “If you’re at a table with someone you don’t know, it’s no longer that. We’re now extended family.”

October 29, 2018

The most common surgical procedures used in wound healing are skin grafts and local flap surgery, where the surrounding skin repairs the epidermis of the open wound.

However, the interventions come with their risks and aren’t always successful, highlighting the need for a more effective, non-surgical intervention using stem cells.

Researchers at the Salk Institute discovered a potential pathway to reprogram mesenchymal cells already in the open wound into new skin cells.

The new technique involved treating skin ulcers on mice. Four reprogramming factors (proteins from adult stem cells) were determined to have excellent wound-healing capacity because they were most likely to develop into basal keratinocytes (skin cells in the innermost layer of the epidermis). Healthy skin covered the ulcers within 18 days. The regrown cells behaved like healthy skin cells up to six months later.